Market News

Oral Route, pulmonary, topical, implantable, injectable, transdermal and transmucosal route analysis.

Collaboration partners to strengthen research in psychiatric diseases.

The so-called method of use patent covers the use of CD95 ligand inhibitors, such as APG101, for the treatment of glioblastoma.

Increased hiring of big data experts and data scientists could help to revitalise the pharmaceutical sector, according to NonStop Recruitment.

Suite of reports provide readers with a comprehensive assessment of biopharmaceutical CMO service quality across three key areas of outsourced manufacturing: small molecule, biologic and fill finish.

Recall due to a potential defect with the dosage cup.

Collaboration focuses on development of novel molecules using SMARTag technology to couple different therapeutic modalities.

Lonza adds two 1000-L single-use bioreactor systems to its current mammalian manufacturing capacity.

Gilles Cottier to lead the company’s PDS business.

The treatment pipeline for Parkinson's disease offers a markedly more promising landscape from the current market, says GBI Research.

Research and Markets has announced the addition of the "Global Pharmaceutical Packaging Market 2016–2020" report to their offering.

Company generates unique monoclonal antibodies that selectively inhibit the supracellular activation of latent TGF-beta 1 in the immune system.

Combination creates leading global biotechnology company projected to deliver double-digit top-line growth with over $20 billion in annual revenues by 2020.

The global breast cancer therapeutics market will increase in value from $10.4 billion in 2014 to $17.2 billion by 2021, says GBI Research.

Yves Buelens has been the plant manager for the Kaysersberg facility since 2014.

Final approval of the company's application is subject to the resolution of minor outstanding topics, such as the use of appropriate language in the product labeling.

The assets will broaden AmpliPhi's IP portfolio and speed the development of its phage therapies

GlobalData report states that the leading driver of this growth will be the anticipated launches of five biologics for the treatment of various forms of vasculitis, including BMS's Orencia, J&J’s Remicade, GSK’s (GSK) Benlysta and Nucala, and Roche’s A...

Genomics’ proprietary statistical analysis tools and integrated multi-phenotype database to be used to support R&D at Vertex Pharmaceuticals.

Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing.

Acquisition adds global rights to novel NDSTM platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product.

Takeda intends to use the facility primarily for the manufacture of Entyvio (vedolizumab) and other biologic products.

Recall issued as a result of a customer reporting an incorrect barcode on the primary bag labeling.

Thousands of patients now using "smart" AdhereTech pill bottle to improve medication adherence.

Novartis plans to launch the next generation connected Breezhaler in 2019.

MannKind is now reviewing its strategic options for Afrezza

Innovative therapies for some skin diseases have stimulated renewed interest in this market among major pharma companies.

Indonesia is poised to become a production base for overseas and local manufacturers of medicines.

Acerus's immediate focus is to find a new Natesto partner in the US.

The issuance of the new patent will expand Tribute's intellectual property protection for Cambia, currently indicated in Canada for the treatment of acute migraine in adults over 18 years of age.

The expansion of the refrigerated container fleet will support the growing demand for ZIMonitor, ZIM's premium reefer cargo tracking service.

The three companies will collaborate to investigate safety, tolerability and preliminary efficacy of avelumab and entinostat in advanced ovarian cancer.

The new business venture, to be owned 51% by Teva and 49% by Takeda, will consist of Teva Takeda Pharma and Teva Takeda Yakuhin.

Collaboration between NIH and Tetra Discovery Partners leads to development of treatment that may affect cognition.

The Guide is intended to assist both customers and suppliers in efficiently managing the initiation, negotiation, implementation, and ongoing maintenance of quality agreements.

The white paper covers the key aspects of how to handle the management of a critical vendor that is under scrutiny and how to minimize the impact on the supply chain.

The total investment is around a half billion euro.

The increased surveillance resulted in the detection of hydrogen cyanide contamination in two shipments of drugs from Tianjin Tianyao Pharmaceuticals Co., Ltd.

As emerging markets have been displaying more robust growth rates than developed markets, they are also witnessing increased patenting activity in pharmaceutical sector.

Emergence of novel therapeutics and minimal generic competition in China, Japan and Australia will drive APAC multiple myeloma market growth to 2021, says GBI Research.

Natco to acquire licence to sell generic Lenalidomide in the US without volume limitation commencing in late January, 2026.

AAIPharma Services/Cambridge Major Laboratories boost oral solid dosage manufacturing capabilities

Company makes significant investments in automation and training to enhance its Quality Systems

Application of fully functional cultured cells as alternative to animal testing.

Bayer is investing USD 335 million in a long-term alliance with CRISPR Therapeutics through new Bayer LifeScience Center unit.

Threshold to focus on clinical trials of tarloxotinib while evaluating potential further development of evofosfamide and other strategic options for the company.

The success of approved products for rare illnesses has opened the door for gene-based treatments of more prevalent diseases, finds Frost & Sullivan.

The XDF (eXtended Dwell Flat) was the stand out product.

A highly innovative and diverse pipeline of 248 products in active development is set to tackle the ever-encroaching obesity crisis.

Research and Markets has announced the addition of the "A Practical Guide to Writing Risk Management Plans (RMPS) (London, UK — 25 January 2016)" conference to their offering.

Micronic has expanded its range of high quality 4.00 mL sample storage tubes to now include non-coded, alphanumeric and 2D data matrix coded formats.

Facility will manufacture biologics for clinical trials.

Alliance will bring cutting-edge research and technical capability for biologics to China with the aim of addressing unmet patient needs in AstraZeneca's main therapy areas of respiratory, inflammation and autoimmunity; cardiovascular and metabolic dis...

Biodegradable and non-toxic drug delivery mechanisms will replace the current methods. These emerging drug delivery mechanisms will enhance the bioavailability of drugs, promote solubility in various environments and ensure targeted delivery.

Sanofi would become a global leader in consumer healthcare and Boehringer Ingelheim would become second largest animal health company.

Research and Markets has announced the addition of the "Evolving Technology Platforms in Pharma-Biotech (TechVision)" report to their offering.

Powdersize brings micronization capabilities that augment Capsugel’s formulation design services and premier bioavailability enhancement technology platform.

Adds product and sales in key global expansion countries.

Employees currently working in Miami will transfer to Innova Softgel, a newly formed subsidiary of Marine Ingredients.

New offering incorporates clinical, commercial and regulatory insight to improve the probability of an asset’s commercial success.

Several similar patent applications have been filed in Canada, Europe, Japan, China and India.

The company plans to use the funding to further strengthen its core R&D service platforms to significantly expand its existing R&D capabilities and capacity and to adopt new and cutting-edge technology to better serve its partners and customers in adva...

Drug pricing advocates target Johnson & Johnson, once one of America’s most trusted brands, after New Jersey company contributes $5.8 million to committee to thwart California ballot measure seeking lower drug prices.

By replacing traditional paper-based systems with MES, companies are able to deal with exceptions in real-time so that batch records and device history records can be reviewed in parallel with manufacturing rather than post production.

The Guide covers GMP principles and active substances used as starting materials.

The newly branded technology and services group warns that current market pressures demand a more holistic approach to global data handling.

Delivers greater manufacturing and supply chain control.

SDC Nutrition is specialized in formulating and manufacturing nutritional products.

The company also expects to launch a transdermal patch formulation upon final FDA approval.

Poli Group comprises three operating companies —Taurus Pharma GmbH, Polichem SA and Polichem Srl.

Kevin will be responsible for leading business development activities around Catalent’s proprietary SMARTag bioconjugation platform.

Catalent to formulate and manufacture Nexium 24HR.

CMC will be strengthened with additional technologies in clinical manufacturing, in particular to its tableting and encapsulating.

Company's research subsidiary, U3 Pharma, to close.

Canada domicile provides similar competitive structure and benefits to Ireland.

The Dry Fog 2 provides rapid decontamination within small rooms and whole suites.

The new version of DF30Plus, which incorporates a neck gasket manufactured with COCe, offers several key benefits.

Water-based “Band-Aid” senses temperatre, lights up, and delivers medicine to the skin.

Company eligible for 180-days marketing exclusivity on a first-to-file Para-IV ANDA.

Sanquin is now licensed to produce bulk material for HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] and GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] (marketed as KIOVIG in the EU) for the European Union, I...

Flooding caused by heavy rain.

Strengthening business platform in China to address diverse medical needs.

The company showcases the innovative Syrina 2.25 auto-injector that brings the flexibility to design a unique form factor and also the full Syrina platform accommodating multiple primary containers and high viscous, high volume injections.

Companies to identify new therapeutic concepts, biomarkers and develop breakthrough medicines to treat pancreatic cancer.

Easy-access webinar e-course from PTI helps pharmaceutical manufacturers implement successful Quality by Design strategies.

Acquisition increases capacity to deliver high quality, locally manufactured oligos.

Receiving up to $38,000,000 plus royalties for licensing deal and $12,000,000 for equity investment at $10.39 per share

Collaboration reinforces Propeller Health's leadership in respiratory digital health and creates a joint opportunity to advance treatment of respiratory disease through digital innovation.

After a series of clinical studies showed positive effects of the patented albumin coating technology, there was a strong demand among physicians to use this graft.

Several of Allergan's flagship products are in the therapeutic areas of dermatology and aesthetics, including brands such as Botox and the cosmetic treatment Juvéderm.

In addition to the Legalon API, Euromed currently supplies high quality products to over 350 customers worldwide accounting for around 70% of its sales.

Pfizer will be responsible for developing and commercialising any potential therapeutic agents (small molecules or biologics derived from StaR antigens) for each target and will have exclusive global rights to any potential resulting agents.

Agreements with three global companies for test development and validation.

Acquisition aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services.

Flexible processing of pre-sterilized syringes.

The EU-CTR replaces the EU Clinical Trials Directive and is designed to improve harmonisation on conducting clinical trials of medicinal products for human use throughout the EU.

Company admits no liability, has released its counterclaims against New York, and has agreed to make a payment of approximately $172,000.

SP Scientific has announced their next series of educational events to be held during 2016 for scientists involved with lyophilization.

Idera is eligible to receive approximately $100 million in development and regulatory milestone payments, including a $2.5 million upfront payment.

A changing pharmaceutical industry needs diversity, new thinking and multi-sector experience, all of which were delivered in spades at Pharma Integrates 2015.

As a result of the combination with Allergan and subsequent integration of the two companies, Pfizer now expects to make a decision about a potential separation of the combined company's innovative and established businesses by no later than the end of...

Attractive financial profile highlighted by expected 2016 net sales of greater than $90 million.

Products include the XDF (eXtended Dwell Flat) — a novel patented elliptical head form, which has been designed to increase dwell time on an existing press without the need for expensive modifications.

Expands oncology capabilities of Charles River Discovery Services.

Technology convergence through partnerships, mergers and acquisitions is yielding a stream of strong candidates, finds Frost & Sullivan.

Civil injunctions and criminal actions against 117 various manufacturers and/or distributors of dietary supplements and tainted products falsely marketed as dietary supplements.

Company believes the resolution of the Warning Letter will enable it accelerate the introduction of new products to the market.

State-of-the-art biologics facility approved by FDA to manufacture bulk drug substance for ADVATE [Antihemophilic Factor (Recombinant)], Baxalta’s market leading treatment for hemophilia A.

Transactions are consistent with the evolution of BMS’s strategic focus, including the decision to discontinue its discovery efforts in virology announced in June.

Rapidly reveals the factors to consider when using ADCC assays for producing precise biosimilar comparability data.

Coated stoppers for sensitive and high-value injectables.

New Gamlen products demonstrated during the show included the Gamlen PCA-500 and TTA systems for Pharmaceutical Research and Development use and the GTP-2 manufacturing model.

Bulk production facility enables company to support large diagnostics customers.

Company’s preliminary investigation indicates tha the incidents of out-of-place softgel capsules in several product batches could be related to a deliberate action by one or more individuals.